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Abstract
Progress in management of critically ill neurological patients has
led to improved survival rates. However, severe residual neuro-
logical impairment, such as persistent coma, occurs in some
survivors. This raises concerns about whether it is ethically appro-
priate to apply aggressive care routinely, which is also associated
with burdensome long-term management costs. Adapting the
management approach based on long-term neurological prognosis
represents a major challenge to intensive care. Magnetic
resonance imaging (MRI) can show brain lesions that are not
visible by computed tomography, including early cytotoxic oedema
after ischaemic stroke, diffuse axonal injury after traumatic brain
injury and cortical laminar necrosis after cardiac arrest. Thus, MRI
increases the accuracy of neurological diagnosis in critically ill
patients. In addition, there is some evidence that MRI may have
potential in terms of predicting outcome. Following a brief
description of the sequences used, this review focuses on the
prognostic value of MRI in patients with traumatic brain injury,
anoxic/hypoxic encephalopathy and stroke. Finally, the roles played
by the main anatomical structures involved in arousal and aware-
ness are discussed and avenues for future research suggested.
Introduction
Severe brain impairment, most notably persistent coma, may
follow traumatic brain injury (TBI), anoxic/hypoxic encephalo-
pathy, or stroke. Although progress in the management of
critically ill neurological patients has led to improved survival
rates [1], some survivors remain in a persistent vegetative or
minimally conscious state. Up to 14% of patients with TBI
remain in a persistent vegetative state after 1 year [2-4], and
their medical cost has been estimated at US$1 to 7 billion
per year in the USA [5]. The possibility that aggressive
medical management may lead to survival with severe brain
impairment raises ethical issues. Adapting the level of medical
care to long-term neurological prognosis is a major challenge
for neurological intensive care. The first step in meeting this
challenge is validation of tools that accurately predict long-
term neurological outcome after severe cerebral insult.
Magnetic resonance imaging (MRI) is more sensitive than
computed tomography at detecting stroke in the early phase,
subtle abnormalities related to anoxic/hypoxic encephalo-
pathy, and diffuse axonal injury (DAI) in patients with TBI. MRI
provides valuable diagnostic information, although it is
cumbersome to perform in the acute phase in comatose
patients who are undergoing mechanical ventilation. Several
MRI sequences and techniques have been used to explore
the structures, metabolism and functions of the brain. The
data supplied by these methods could be used to predict
long-term neurological outcome.
In this review we briefly describe the MRI sequences and
techniques used in critically ill neurological patients, and then
we discuss their prognostic value in comatose patients with
TBI, anoxic/hypoxic encephalopathy, or stroke. Finally, we
discuss the prognostic influences of the main anatomical
structures that are involved in arousal and awareness, and we
suggest avenues for future research.
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Magnetic resonance imaging sequences and
techniques
Conventional magnetic resonance imaging
Conventional MRI relies chiefly on four sequences [6]. Fluid-
attenuated inversion recovery (FLAIR) is the primary
sequence used in neuroradiology (Figure 1). It detects brain
contusion, brain oedema and subarachnoid or intraventricular
haemorrhage, as well as the resulting ventricular dilatation or
herniation. The T2*-weighted sequence is more sensitive to
intraparenchymal blood than is FLAIR. This sequence can
also reveal haemorrhagic DAI [7,8]. The T2-weighted
sequence completes the FLAIR sequence and provides
greater detail on brainstem and central grey matter. Finally,
diffusion weighted imaging (DWI) is sensitive to random
movement of water molecules. This sequence shows cerebral
oedema and distinguishes cytotoxic from vasogenic oedema.
It is used chiefly in patients with ischaemic stroke.
Conventional MRI provides an initial evaluation of brain
lesions. However, when it is used alone it fails to predict
outcome accurately.
Magnetic resonance spectroscopy
This sequence is a noninvasive technique for assessing brain
metabolism  in vivo. Proton-magnetic resonance spectro-
scopy (MRS) is most commonly used. Four main markers are
studied: the peak of N-acetyl-aspartate (NAA), an amino acid
present in neurones, which reflects the status of neuronal
tissue; creatine, found in glia and neurones, which serves as
a point of reference because its level is believed to be stable;
choline, a constitutive component of cell membranes, which
reflects glial proliferation or membrane breakdown [9]; and
lactate, a marker of anaerobic metabolism and therefore of
ischaemia [10]. As shown in Figure 2, three main pons
monovoxel profiles may be observed in patients with TBI.
Diffusion tensor magnetic resonance imaging
Diffusion tensor imaging (DTI), derived from DWI, measures
the degree and direction of water diffusion (anisotropy).
Water diffusion anisotropy reflects the integrity of white
matter tracts. Pathophysiological mechanisms that can alter
water diffusion anisotropy include DAI, effects of intracranial
hypertension and disconnection of white matter tracts.
Magnetization transfer imaging
This sequence is based on the principle that structure-bound
protons undergo T1 relaxation coupling with protons in the
aqueous phase. Saturated protons in macromolecules
exchange longitudinal magnetization with protons in the
aqueous phase, leading to a reduction in signal intensity.
Magnetization transfer imaging has been found to be
sensitive for detecting white matter lesions in several
neurological conditions [11,12].
Functional magnetic resonance imaging
Functional MRI may reveal foci of cerebral dysfunction in
regions that look structurally intact on conventional MRI.
Imaging is based on changes in the oxidative state of
haemoglobin, which reflects regional brain activation.
Functional MRI remains difficult to perform in critically ill
unstable patients and, consequently, few teams have
acquired the equipment and experience necessary to apply
this technique [13]. The few available studies conducted in
comatose patients with TBI showed a correlation between
prefrontal/cingulated cortical activation disturbation and
cognitive impairments [14,15]. However, functional MRI was
performed in these studies at a distance from the injury.
Magnetic resonance imaging findings in
specific critical neurological conditions
Traumatic brain injury
Conventional magnetic resonance imaging
MRI was first used to investigate patients with TBI in a 1986
study of 50 patients [16]. The three main findings, which have
since been confirmed, were as follows: MRI identified lesions
more frequently than did computed tomography; brain lesions
were common after TBI; and although patients who regained
consciousness rapidly had no lesions in fundamental deep
Figure 1
FLAIR and T2* sequences in a patient with an arteriovenous
malformation. (a) Axial fluid-attenuated inversion recovery (FLAIR)
sequence showing hypersignal in the left temporal lobe. (b) Axial T2*
sequence showing mild hyposignal in the same area suggestive of
bleeding. (c) Different section of the axial FLAIR sequence showing
hypersignal surrounded by hyposignal. Bleeding cannot be confirmed.
(d) Axial T2* sequence clearly showing hyposignal lateral to the left
putamen. The patient has bleeding from the arteriovenous
malformation.Page 3 of 12
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brain structures, some of them had severe cortical lesions.
Several descriptions of MRI lesions in TBI patients have been
reported since that initial study was published (Table 1)
[17-21], although few of them focused on the prognostic
value of MRI [17-20]. Conventional MRI findings that strongly
predicted outcome included DAI, total lesion burden and DAI
in the brainstem.
DAI is the most common primary lesion in TBI patients [22,23]
and may be the most common cause of poor outcome [22-24].
DAI may be ischaemic or haemorrhagic [7,8]. Ischaemic DAI is
seen as a hypersignal on DWI or FLAIR, with no abnormality on
the T2* sequence [25]. The hypersignal with DWI disappears
within about 2 weeks. Conversely, haemorrhagic DAI appears
as a hyposignal on the T2* sequence, with normal DWI
findings. It has been proposed [22] that DAI location could be
classified into the following stages: stage 1, frontal and
temporal white matter; stage 2, lobar white matter and
posterior part of corpus callosum; and stage 3, dorsolateral
midbrain and pons. With outcomes defined as Glasgow
Outcome Scale [26] scores of 2 to 3 versus 4 to 5, none of the
33 patients with good outcome in another study [27] had
haemorrhagic DAI (Table 1). DAI appears to be a major
determinant of poor outcomes, although its use as an outcome
predictor in the individual patient remains difficult. Whether the
correlation between DAI and outcome is due to the total lesion
burden or to DAI location remains debated.
In several prospective studies, lesion burden was associated
with outcome irrespective of DAI location (Table 1)
[17,19,28]. Among 40 prospectively enrolled patients with
severe TBI, lesions by FLAIR and T2*-weighted sequences
increased progressively with GOS score groups 1 to 2, 3,
and 4 to 5 [17]. Similar results were obtained in a study
comparing 42 patients with persistent vegetative state with
38 patients who recovered consciousness [19].
A number of studies have focused on the value of DAI
location in predicting outcome [19,29-31]. Brainstem lesions
in the pons and mesencephalon appear to be the most
potent markers of poor prognosis, most notably when they
are bilateral and symmetrical [18,19,29,31]. In a prospective
study conducted in 61 patients (Table 1) who were studied
within 7 days of TBI [18], all patients with bilateral pontine
lesions died as compared with 9% of patients with no
brainstem lesions. These results were confirmed by the same
group in a prospective study of 102 comatose patients [29]
using the following four-stage grading system: grade I,
lesions of the hemispheres only; grade II, unilateral lesions of
the brainstem at any level with or without supratentorial
lesions; grade III, bilateral lesions of the mesencephalon with
or without supratentorial lesions; and grade IV, bilateral
lesions of the pons with or without any of the lesions of lesser
grades. Mortality increased gradually from 14% with grade I
lesions to 100% with grade IV lesions. These findings were
corroborated by two independent studies [19,31] (Table 1).
We recently confirmed the prognostic value of brainstem
lesions in the upper pons and lower midbrain in a study of 73
patients [32]. Bilateral pontine lesions carry a high mortality
rate and predict poor neurological outcomes.
Three studies showed that corpus callosum lesions were
associated with poor outcomes [19,30,31] (Table 1). How-
ever, these lesions may merely represent markers for severe
initial injury. In addition to lesion burden, both total lesion
volume and frontal lobe lesion volume on FLAIR images
correlated significantly with clinical outcomes [30]. Never-
theless, evaluating DAI lesion volume is difficult (most notably
when the lesions are small), time consuming, cumbersome
and subject to inter-rater variability.
The presence of severe DAI and a heavy lesion burden are
associated with permanent neurological impairment.
However, these factors are difficult to use in the individual
patient, especially to distinguish GOS score 2 from GOS
score 3. In TBI patients, brainstem lesions are easily identified
by MRI. In our experience, they are associated with poor
outcomes, most notably when they are posterior and bilateral.
Available online http://ccforum.com/content/11/5/230
Figure 2
Magnetic resonance spectroscopy profile of the pons after traumatic brain injury. (a) Normal profile. The peak of N-acetyl-aspartate (NAA) is higher
than the peaks of choline (Cho) and creatine (Cr). (b) Neuronal loss profile. The NAA peak is decreased, nearly to the level of the Cr peak. The
NAA/Cr ratio is lower than in panel a. (c) Gliosis profile: increased Cho peak with no change in the Cr or NAA peak. Adapted from [17].Critical Care    Vol 11 No 5 Weiss et al.
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.Posterior brainstem lesions in the periaqueductal grey matter
are probably more relevant than anterior brainstem lesions as
predictors of poor outcomes in patients with brainstem stroke
[21] or TBI [19]. In clinical practice, treatment limitation may
deserve consideration in patients who have large bilateral
lesions in the posterior part of the pons after TBI.
Magnetic resonance spectroscopy
Several MRS studies have been conducted in TBI patients
(Table 2). Some of them were purely descriptive [33], others
assessed only the neuropsychological outcomes [34,35], and
yet others focused on global outcome as evaluated using the
GOS or Disability Rating Scale [17,36-42].
Compared with control individuals, TBI patients exhibited
decreased NAA levels, decreased NAA/creatine ratios and
increased choline levels (Table 2) in all brain regions
evaluated [35-39,41,42]. Increased lactate levels were
seldom found in TBI patients, contrary to patients with other
brain injuries [38]. The NAA/creatine ratio appeared to be the
best outcome predictor. Low NAA/creatine values correlated
with poor outcomes when they were located in the frontal
[37,39], frontoparietal [43], or occipitoparietal lobes [36,40];
the splenium of the corpus callosum [41]; the thalami [42];
the pons [17]; or a voxel including the corpus callosum, the
white matter, and part of the hemispheric cortex [38].
These studies are heterogeneous (Table 2) in terms of patient
selection, time from TBI to MRS, voxel location, method of
outcome assessment and timing of outcome assessment. For
instance, among studies of patients with TBI, one included
only patients in a vegetative state [42], another included
patients with severe TBI [17] and a third excluded patients
with early initial coma [36]. These differences in patient
selection may be associated with differences in severity of
brain oedema and in associated hypoxia and herniation,
thereby introducing bias into the interpretation of the results.
MRS findings vary greatly according to time since TBI. Four
phases may be distinguished: an acute phase, which lasts
24 hours after TBI; an early subacute phase, which spans
from the days 1 to 13; a late subacute phase, from days 14 to
20; and a chronic phase, which starts on day 21. Only two
studies included patients at the acute phase [38,40], and
only one of these included all patients before 72 hours [38].
Two studies were conducted from the early subacute phase
to the first month [17,37] and one began inclusion in the late
subacute phase but included patients up to 11 months after
TBI [43]. Four studies focused on the chronic phase; in two
of these studies, patients were included 3 weeks to 6 months
after TBI [36,39] and in the other two studies they were
included 2 months to 8 months after TBI [39,42].
Although NAA/creatine ratios were similar across studies, the
results should be interpreted with caution because experi-
mental in vitro and in vivo data suggest differences in the
underlying pathophysiological mechanisms and in the time
course of the lesions [44-46]. To interpret these results reliably,
information on NAA values over time are needed. Experiments
conducted in vitro [44] and in vivo [45,46] show an early NAA
decrease starting within a few minutes after TBI and reaching
the trough value within 48 hours. This finding explains why
spectroscopic disturbances may require 48 hours for
visualization [47]. NAA levels remain stable within the first
month after TBI, supporting the validity of MRS assessment
during the second or third week [48,49]. Later on, between
6 weeks and 1 year after TBI, NAA levels may decrease [9,37].
Partial recovery of NAA levels has been suggested and may
indicate recovery of mitochondrial function [41].
Another important factor that varied across studies was MRS
voxel location (Table 2). Voxels were located in the hemi-
sphere (the occipitoparietal, frontoparietal, or frontal lobes),
corpus callosum, thalamus, or brainstem (the pons). Because
whole brain analysis is time consuming, voxels are typically
restricted to the areas most affected by DAI, namely the lobar
white matter, corpus callosum and upper brainstem [50].
Estimation of NAA in the whole brain may improve the
prognostic value of MRS [41]. A good compromise may be a
voxel encompassing the corpus callosum, white matter and
part of the hemispheric cortex [38].
Studies also differed in their definitions of poor and good
GOS outcome groups: comparisons involved GOS score 1
to 2 versus GOS score 3 to 5 [39], GOS score 1 to 4 versus
GOS score 5 [41], or GOS score 1 to 2 versus GOS score
4 to 5 [17]. Finally, the time from TBI to outcome assessment
varied from 3 to 18 months (Table 2), further complicating
comparisons because neurological status may improve for up
to 1 year after TBI.
Although MRS has superseded conventional MRI, the combi-
nation of these two techniques may be useful [17]. Variations
in the NAA/creatine ratio over time have not been studied in a
large TBI patient population. The above-mentioned variability
in NAA levels constitutes the main limitation of this technique.
To overcome this limitation, repeated studies at intervals of 1
to 2 weeks are probably needed. In our experience, variations
in the NAA/creatine ratio are minimal in many patients. We
agree with Sinson and coworkers [41] that whole brain NAA
estimation might improve the prognostic value of MRS.
Absence of dysfunction by MRS is a valuable finding; in a
patient with normal results by both conventional MRI and
MRS, a poor outcome is unlikely. However, we have seen a
few patients with normal conventional MRI and MRS findings
who had poor outcomes, probably related to white matter
damage detected as DTI abnormalities.
Diffusion tensor magnetic resonance imaging
Initial reports of DTI in TBI patients suggest that this
technique may demonstrate alterations in white matter
connections that are missed by conventional MRI [51]. DTI
provides information on the physiological status of fibre
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.bundles, thus complementing the metabolic and biochemical
information supplied by MRS. At present, little is known about
the prognostic value of DTI in patients with TBI. DTI findings
correlated with clinical status in patients with multiple
sclerosis or neurodegenerative disease [52,53]. In a mouse
model of TBI, DTI parameters were significantly reduced in
the injured brain, whereas conventional MRI showed no
significant changes [54]. Furthermore, changes in relative
anisotropy correlated significantly with the density of stained
axons on histological sections.
In a study comparing 20 TBI patients and 15 healthy control
individuals, fractional anisotropy was reduced in the internal
capsule and splenium of the corpus callosum and correlated
with Glasgow Coma Scale score and Rankin score at
discharge in the TBI patients [55]. Similar findings have been
reported in children [56]. Anecdotal case reports of DTI
abnormalities in TBI patients have been reported [57,58]. In
two patients who recovered partially after 6 years and
19 years, respectively, in a minimally conscious state, DTI
disclosed increased anisotropy within the midline cerebellar
white matter over an 18-month period [59]. This anisotropy
increase correlated with an increase in resting metabolism,
measured using positron emission tomography, which
suggests that axonal regrowth might underlie increases in
anisotropy. Larger studies of DTI variations over time are
needed. In our institution, comatose patients have been
included in a prospective DTI study for the past 3 years.
Patients with major connectivity abnormalities in both
hemispheres and the brainstem were at increased risk for
poor outcomes. A large multicentre prospective study is
ongoing in France to assess the usefulness of combining DTI
with MRS.
Magnetization transfer imaging
Magnetization transfer imaging is sensitive for detecting white
matter lesions in patients with multiple sclerosis, progressive
multifocal leukoencephalopathy, or wallerian degeneration
[11,12]. Preliminary results in TBI are promising [60,61]. The
magnetization transfer ratio was decreased in TBI patients
[60,61]. Out of 28 TBI patients, eight had abnormal
magnetization transfer ratios, and all eight had persistent
neurological deficits [62]. In another study, however, no
correlation was found between GOS score and abnormal
magnetization transfer ratio [41].
Anoxic/hypoxic encephalopathy
Anoxic/hypoxic encephalopathy is a devastating condition; its
development after prolonged cerebral hypoxia is often difficult
to predict on clinical grounds. No controlled studies of
routine MRI in large numbers of cardiac arrest patients have
been reported. Anecdotal case reports and small series are
available [63-67]. As with TBI, MRI findings in hypoxic/anoxic
encephalopathy go through four phases [66]: an acute
phase, which lasts 24 hours after anoxia or hypoxia; an early
subacute phase, from days 1 to 13; a late subacute phase,
from days 14 to 20; and a chronic phase, starting on day 21.
MRI findings in patients with hypoxic brain damage are
complex but distinctive. Brain swelling, cortical laminar
necrosis, hypersignal of basal ganglia, delayed white matter
degeneration and atrophy occur in succession, as shown in
Table 3 [63,66,67]. During the acute and early subacute
phases, DWI and T2-weighted sequence show hypersignals
in the cortex, thalamus and basal ganglia. DWI may be more
sensitive for detecting mild hypoxic/anoxic injury within the
first few hours, and the hypersignal may occur first in the
cerebral cortex and later in the basal ganglia. During the late
subacute phase the hypersignals previously seen by DWI
tend to fade, and diffuse white matter abnormalities denoting
delayed anoxic leukoencephalopathy may develop [68].
During the chronic phase diffuse atrophy and dilatation of the
ventricles are visible, whereas DWI is normal.
The three main series published to date included ten [66],
eight [67] and six [63] patients. Although the small numbers
of patients is a limitation, the succession of four phases was
confirmed in several case reports and supported by findings
of histological and animal studies [9,12,16,67], indicating far
greater vulnerability of grey matter to hypoxia as compared
with white matter. This difference in vulnerability may explain
why some brain regions are more susceptible than others to
diffuse insults such as hypoxia or anoxia [2,11,29,66].
A few studies recorded both MRI findings and long-term
outcomes in patients with hypoxic/anoxic encephalopathy
[64,67,69]. Diffuse cortical abnormalities by DWI in the acute
or early subacute phase appear to be of unfavourable
prognostic significance. Of six patients with hypoxic encepha-
lopathy investigated by sequential MRI, the only patient who
recovered a GOS score greater than 3 had hypersignals in
watershed zones in the parieto-occipito-temporal cortex
without cortical hypersignal by DWI. In a study of 10 patients
who had suffered a cardiac arrest, FLAIR and DWI showed
that eight patients had diffuse abnormalities in the
cerebellum, thalamus, frontal and parietal cortices, and
hippocampus [69]. None of the patients with cortical
structure abnormalities recovered beyond a severely disabled
state. In another prospective study, the prognostic value of
DWI was evaluated in 12 patients within 36 hours after global
cerebral hypoxia [64]. DWI findings correlated with clinical
outcomes after 6 months. The three patients with short resus-
citation times had a good recovery and normal DWI findings.
Of the remaining nine patients, all had DWI abnormalities and
developed a vegetative state. Thus, diffuse cortical
hypersignals by DWI appear to predict a poor outcome.
Conversely, several reports describe delayed anoxic
encephalopathy with a good final outcome and resolution of
MRI abnormalities. Therefore, finding diffuse hypersignals in
the white matter by either DWI or T2/FLAIR weighted
sequences should not lead to treatment limitation decisions.
In general, whether MRI findings can be used to guide
treatment limitation decisions remains unclear. In our unit,
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hypersignals by DWI or cortical laminar necrosis images after
prolonged cardiac arrest, provided the MRI findings are
consonant with the clinical examination or electrophysiological
data. In contrast, a patient with normal MRI findings after anoxia
should probably be re-evaluated 1 or 2 weeks later by clinical
examination, electrophysiological testing and MRI.
Few data are available on MRS findings after anoxia [70,71].
No studies were specifically designed to assess the
prognostic value of DTI in patients with anoxic/hypoxic
encephalopathy. The unique ability of DTI to distinguish
between white matter and grey matter, allowing separate
quantitative assessment of these two tissues, should be of
particular interest in anoxic/hypoxic encephalopathy.
Severe hypoglycaemia has been likened to hypoxic encepha-
lopathy. Imaging study data in patients with hypoglycaemic
coma are scant [63,72,73]. Interestingly, DWI abnormalities
can mimic stroke in patients with hypoglycaemic coma
[74,75]. Rapid improvements in DWI and MRI abnormalities
after glucose infusion were recently reported [76].
Ischaemic stroke
Ischaemic stroke causes coma in two main settings, namely
malignant stroke and basilar artery occlusion. We focus on
these two situations, and we do not discuss the prognostic
value of MRI after stroke without coma.
In a study of 37 patients with acute middle cerebral artery
infarction, early quantitative DWI findings predicted
progression to malignant stroke, which occurred in 11
patients [77]. Factors that predicted malignant stroke were
as follows: size of the region with apparent diffusion
coefficient (ADC) <80% greater than 82 ml; ADC in the core
of the stroke <300 mm2/s; and relative ADC within the ADC
<80% of the lesion under 0.62. Another study evaluated 28
patients, of whom 11 experienced malignant stroke [78]. The
best predictor of malignant stroke within 14 hours of stroke
onset was infarct volume by DWI greater than 145 cm3,
which was 100% sensitive and 94% specific. Regarding
brainstem stroke, a retrospective study of 47 patients
showed that coma, which was a feature in nine patients, was
associated with lesions in the posterior pons and lower
midbrain [21]. The patients who died had all bilateral
brainstem lesions in this area. None of the patients with
bilateral lesions survived. Although the number of patients
was small in the study, the results are consonant with clinical
experience that brainstem stroke with coma and large
brainstem lesions has a poor outcome and that some patients
who are initially comatose with limited anterior brainstem
infarction eventually experience good outcomes.
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Table 3
Chronological magnetic resonance imaging findings in anoxic/hypoxic encephalopathy
Acute phase  Early subacute phase  Late subacute phase  Chronic phase 
(<24 hours) (24 hours to day 13) (days 14 to 20) (>21 days)
Characteristics Brain swelling Brain swelling Absence of brain swelling Diffuse atrophy and 
dilatation of the ventricles
DWI Hypersignals in the cortex,  Hypersignals in the cortex,  Progressive disappearance  Normal
in the thalamus and in the  in the thalamus and in the  of hypersignals found 
basal ganglia basal ganglia previously
T2 Hypersignals in the cortex,  Hypersignals in the cortex,  Hypersignals of the cortex,  Normal or possible 
in the thalamus and in the  in the thalamus and in the  the thalamus, the basal ganglia  hypersignals of the cortex, 
basal ganglia basal ganglia. Possible  and the pons the thalamus, the basal 
subcortical hyposignals ganglia and the pons
T1 No abnormalities No abnormalities Possible spontaneous  Can be normal
subcortical and basal ganglia 
hypersignals
T1 with  No abnormalities Possible subcortical  Possible subcortical  No abnormalities
gadolinium  enhancement suggestive of  enhancement suggestive of 
enhancement cortical laminar necrosis cortical laminar necrosis
Comments DWI seems more sensitive  Hypersignals on both DWI and  In some cases, appearance of  In some cases, 
to mild hypoxic/anoxic injury  T2 become more intense,  diffuse white matter,  hypersignals of the cortex 
in the first hours, and the  particularly in the thalamus and  abnormalities of delayed anoxic  and hyposignals in the 
hypersignal in cerebral  the basal ganglia leukoencephalopathy on both  subcortical zone on both 
cortex seems more  DWI and T2 T2 and T1, suggestive of 
precocious than in the basal  cortical laminar necrosis
ganglia
DWI, diffusion weighted imaging; T1, T1 weighted sequence; T2, T2 weighted sequence. Adapted from [66,67].DTI has been used to assess outcomes after stroke [79],
although we are not aware of studies of MRS or DTI to
predict outcomes after malignant or brainstem stroke. In a
study of 12 patients with subcortical infarcts involving the
posterior limb of the internal capsule, a decrease in fractional
anisotropy was detected by DTI, indicating secondary
degeneration of the fibre tract proximal and distal to the
primary ischaemic lesion [80]. Fibre tract degeneration
occurred gradually, which might have hampered functional
recovery. In patients with brainstem stroke or malignant
stroke, DTI may be of considerable value for assessing fibre
tract degeneration, thus predicting chances of recovery.
Ascending reticular activating system and
prognosis of brain injuries
Several brain areas involved in the prognosis of TBI or stroke
play a role in consciousness [17,19,21,81]. Figure 3 shows
the anatomical regions involved in arousal and conscious-
ness. Brainstem lesions have been shown to influence the
prognosis of patients with coma after TBI or stroke
[17,19,21,81]. Bilateral brainstem lesions were associated
with poorer outcomes [21,81], and the target area appeared
to be the posterior pons and lower midbrain, where the
ascending reticular activating system (ARAS) nuclei are
located. An MRI study of 88 patients in a vegetative state
after TBI confirmed the prognostic importance of lesions in
this area [19]. The ARAS projects in part to the basal fore-
brain through the hypothalamus by its ventral pathway, as
shown in Figure 3. Several pathological studies showed a
high rate of basal forebrain lesions in humans who died after
head injuries [82], and we found that hypothalamic and basal
forebrain lesions were associated with poor outcomes in TBI
patients [32]. Histological evidence of neuronal damage in
the nucleus basalis of Meynert (the main nucleus of the basal
forebrain) was found in most of the patients who died after
head injury [82]. The ARAS projects to the reticular thalamic
nuclei through its dorsal pathway (Figure 3). Focal damage to
the thalami was documented in pathological studies of
patients in vegetative state [83,84]. All three pathways lead
to cortical arousal. Widespread cortical damage (as
described in anoxic/hypoxic encephalopathy [83,85]) and
widespread white matter damage (as described in TBI
patients [86]) may result in inability to arouse cortical areas
(vegetative state). Clinical findings in patients with TBI
suggest that impairment in consciousness may correlate with
depth of the deepest lesion [20,87]. Although lesions to the
ARAS or its projections may correlate with severity of the
initial injury or the existence of herniation, another possibility
is that they directly contribute to the prognosis. Studies
involving multimodal investigations would provide valuable
insight in this area [88].
Avenues for research
Data from patients with TBI, stroke, or anoxic encephalopathy
suggest that specific MRI findings may hold promise for
outcome prediction. Large studies are not yet available, even
in patients with TBI. Given the major ethical, human and
economic issues involved, there is an urgent need for large
prospective multicentre studies. Only small numbers of
patients eligible for such studies are admitted to medical or
surgical intensive care units, and few neurosurgical or
neurological intensive care units exist; therefore, a multicentre
design is essential to ensure recruitment of a sufficiently large
population. In our institution, which is a neurosurgical
intensive care unit in a tertiary hospital, multimodal prospec-
tive imaging by conventional MRI, MRS and DTI is performed
routinely in all patients who are still comatose after 2 weeks.
A multicentre study funded by the French Ministry of Health is
under way.
Conclusion
Patients with severe brain injury, most notably those who
remain comatose, generate huge health care costs. Adapting
the level of medical care to the neurological outcome is a
major challenge currently faced by neurological intensive
care. Meeting this challenge will require the development of
tools that reliably predict long-term neurological outcomes.
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Figure 3
Anatomical substratum of arousal and awareness. Consciousness
involves two main components: arousal and awareness of oneself and
of the environment. Awareness is dependent on the integrity of specific
anatomical regions [89]. The ascending reticular activating system
(ARAS), the primary arousal structure, is located in the upper pons and
lower midbrain in the posterior part of the upper two-thirds of the
brainstem [90,91]. A ventral pathway (black solid arrows) projects to
the hypothalamus (hypo) and basal forebrain (Bfb); a dorsal pathway
(black dashed arrows) projects to the reticular nuclei of the thalamus
(thal); and a third pathway (light grey arrows) projects directly into the
cortical regions [90]. From the basal forebrain, two main bundles
project diffusely to several cortical areas [92]. The reticular nuclei of
the thalamus connect to other nuclei in the thalamus. They are involved
in a thalamo-cortical circuit [93] that controls cortical activity. Some
regions of the cerebral cortex may also make specific contributions to
consciousness [94].Most MRI studies to date were conducted in patients with
TBI. By conventional imaging, presence of bilateral lesions in
the dorsolateral upper brainstem appears to be the factor of
greatest adverse prognostic significance. With MRS, low
NAA/creatine ratio in the hemispheres and in the pons
predicts a poor outcome. In anoxic/hypoxic encephalopathy,
the factor of greatest adverse significance appears to be the
presence of diffuse cortical abnormalities by DWI. However,
data are scarcer than in the field of TBI. Finally, regarding
brainstem stroke, posterior lesions appear to be associated
with poor outcome.
The prognostic value of imaging studies could be improved
by combining several techniques and sequences, for instance
by combining several MRI sequences or by combining MRI
with electrophysiological studies or clinical data. Complete
destruction of arousal structures is consistently associated
with poor outcome. Multimodal MRI is a promising technique
that can be expected to provide accurate prediction of
neurological outcome in the near future.
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